Cargando…

Synergistic effects of curcumin and bevacizumab on cell signaling pathways in hepatocellular carcinoma

The aim of the present study was to explore the effects of curcumin in combination with bevacizumab on the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR)/K-ras pathway in hepatocellular carcinoma. A total of 30 Sprague Dawley (SD) rats were randomly divided into five groups: Control...

Descripción completa

Detalles Bibliográficos
Autores principales:	GAO, JIAN-ZHI, DU, JING-LI, WANG, YONG-LING, LI, JIA, WEI, LI-XIN, GUO, MING-ZHOU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246621/ https://www.ncbi.nlm.nih.gov/pubmed/25435978 http://dx.doi.org/10.3892/ol.2014.2694

Ejemplares similares

Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
por: Zheng, Yongshun, et al.
Publicado: (2022)

Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways
por: Yan, Xijing, et al.
Publicado: (2023)

Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma
por: Miyazaki, Katsuki, et al.
Publicado: (2023)

Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells
por: Omeroglu Ulu, Zehra, et al.
Publicado: (2023)

The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß‐catenin signaling
por: Krug, Sebastian, et al.
Publicado: (2021)

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma
por: Le, Thi Bich Uyen, et al.
Publicado: (2020)

LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling
por: Shao, Jiang, et al.
Publicado: (2020)

Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma
por: Ding, Jia, et al.
Publicado: (2021)

Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
por: Gao, Jian, et al.
Publicado: (2021)

Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB
por: Xu, Ting, et al.
Publicado: (2020)

Sorafenib-Loaded Cu(2−x)Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma
por: Huang, An-Tian, et al.
Publicado: (2022)

Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
por: Gao, Ruoling, et al.
Publicado: (2022)

“One-stop” synergistic strategy for hepatocellular carcinoma postoperative recurrence
por: Liu, Yiming, et al.
Publicado: (2023)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
por: Suga, Takayoshi, et al.
Publicado: (2023)

Synergistic anti-liver cancer effects of curcumin and total ginsenosides
por: Deng, Zhe, et al.
Publicado: (2020)

Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically
por: Zhang, Xin, et al.
Publicado: (2021)

Oridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathway
por: Zhang, Hua-Peng, et al.
Publicado: (2017)

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2021)

Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis
por: Li, Yan-Ping, et al.
Publicado: (2017)

Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells
por: Kong, Zwe-Ling, et al.
Publicado: (2019)

Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China
por: Gong, Hongyu, et al.
Publicado: (2023)

Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway
por: Shi, Li-Wei, et al.
Publicado: (2020)

Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β-catenin signal activation
por: Kuwano, Akifumi, et al.
Publicado: (2022)

APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway
por: Zhai, Mengying, et al.
Publicado: (2020)

Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway
por: He, Jin-Dan, et al.
Publicado: (2016)

Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer
por: Gong, Feirong, et al.
Publicado: (2021)

Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
por: Brackenier, Cedric, et al.
Publicado: (2023)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2023)

The Synergistic Effects of Curcumin and Chemotherapeutic Drugs in Inhibiting Metastatic, Invasive and Proliferative Pathways
por: Younes, Maria, et al.
Publicado: (2022)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
por: Zhang, Yafei, et al.
Publicado: (2012)

Curcumin ameliorates DSS-induced colitis in mice by regulating the Treg/Th17 signaling pathway
por: Wei, Cheng, et al.
Publicado: (2021)

Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways
por: Li, Yousong, et al.
Publicado: (2021)

Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Ailioaie, Laura Marinela, et al.
Publicado: (2020)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
por: Liu, Zhili, et al.
Publicado: (2023)

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023)

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
por: Song, Ye, et al.
Publicado: (2021)

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
por: Xin, Yujing, et al.
Publicado: (2022)

Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways
por: Shang, Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2erlscbd52qom08kioojjsobug